Aveanna Healthcare beats Q3 revenue estimates and raises forecast
AVAH•Aveanna Healthcare's third-quarter revenue rose 12% year over year to $695.5 million, beating analyst estimates of $679.51 million. It raised its 2026 revenue guidance to more than $2.695 billion and adjusted EBITDA guidance to more than $374 million.
1. Quarterly results
Third-quarter adjusted EBITDA rose 25% year over year to $100.1 million. Net income was $45.5 million, and earnings per share were $0.20.
2. Raised outlook
Aveanna raised its full-year 2026 revenue guidance to greater than $2.695 billion and its adjusted EBITDA forecast to greater than $374 million. Revenue increased across all three business segments, with the PDS segment contributing the most.
